| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-5347(05)67536-2 |
| P698 | PubMed publication ID | 10799176 |
| P50 | author | David G. Bostwick | Q119000792 |
| P2093 | author name string | Weaver AL | |
| Cheng L | |||
| Myers RP | |||
| Leibovich BC | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 1756-1760 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Journal of Urology | Q15709979 |
| P1476 | title | Outcome prediction with p53 immunostaining after radical prostatectomy in patients with locally advanced prostate cancer | |
| P478 | volume | 163 |
| Q81055669 | Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population |
| Q36308536 | P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection |
| Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
| Q77359704 | Relationship of p21(WAF-I) protein expression with prognosis in advanced prostate cancer treated by androgen ablation |
| Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
| Q38451690 | The prognostic value of p53 and DNA ploidy following radical prostatectomy |
| Q34394824 | The role of imaging studies and molecular markers for selecting candidates for radical prostatectomy |
| Q38063121 | The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review |
| Q80652828 | [Prognosis and predictive factors of prostate cancer in the prostatic biopsy] |
| Q45262425 | p53 and cyclooxygenase-2 expression are directly associated with cyclin D1 expression in radical prostatectomy specimens of patients with hormone-naïve prostate cancer |
Search more.